Data on Crestor could expand statin market, experts say

11/3/2008 | Wall Street Journal, The

AstraZeneca is scheduled Sunday to present results from a 17,802-patient clinical trial of Crestor, a cholesterol-lowering statin, that could significantly widen the market for such drugs, experts said. Other experts said the findings could spur changes to cholesterol-treatment guidelines, including a wider use of C-reactive protein in screening patients for heart risks.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY